Search

News

  • news
    04.12.2017 Genetics have shown the place in the genome where all allergic reactions are associated

    Scientists have identified more than 100 genes acting as risk factors for severe allergic reactions, hay fever, eczema and asthma, Zee News reports. Earlier, it has been already established that these ailments have a single genetic basis. However, geneticists did not know where the problem genes affecting the functioning of the immune system exactly were.

  • news
    30.11.2017 Scientists dispelled the myth of popular medicines against heartburn

    Previous studies have shown that proton pump inhibitors, which are usually prescribed for heartburn and other acid-related diseases, increase the risk of developing dementia. But now experts have disproved this. According to The Deccan Chronicle, the researchers have analyzed the data of 3484 adults aged 65 and over.

  • news
    28.11.2017 A new remedy may help to relieve chronic hepatitis

    The developers have reported on the successful completion of Myrcludex B interim tests. Myrcludex B is a drug intended to patients with chronic hepatitis B (delta agent). As "Remedium" notes, the drug has been tested on 120 patients for 24 weeks. During that time the volunteers had no serious side effects. This proves the safety of the therapy.

  • news
    27.11.2017 Medicine for multiple sclerosis will fight against resistant bacteria

    Glatiramer acetate is a medicinal product, used to treat multiple sclerosis for 20 years. It turns out that it is able to cope with antibiotic resistant bacteria. As Zee News notes, experts say that the drug is safe and has no serious side effects.

  • news
    23.11.2017 Discovery: genes determine the life expectancy of cancer patients

    A new study, carried out by scientists from the United States, involved 365 people suffering from pancreatic adenocarcinoma. The tumor could be removed surgically. The researchers have found that the life expectancy of patients depends on changes in the four genes, The Indian Express reports.

  • news
    17.11.2017 Breakthrough: Genetics have partially restored vision to blind people

    A group of scientists has created a new gene therapy designed to help patients who lost their vision due to a hereditary disease - Leber congenital amberosis. The therapy can restore vision to the point where a person can navigate in a maze in dim light, The Deccan Chronicle reports.

  • news
    16.11.2017 The use of statins after a heart attack may save your life

    As The Daily Mail notes, the risk of another heart attack, stroke and premature death is reduced by approximately 25% in people taking statins (cholesterol-lowering drugs) after a stroke or heart attack. A new study carried out by scientists from the United States has made such conclusions.

  • news
    15.11.2017 A unique implant is able to improve memory

    A brand new brain implant has been designed by experts from the University of Southern California. It stimulates the brain region associated with learning ability and memory. Thanks to the implant, experiment participants began to cope with the task for memory much better, The Daily Mail reports.

  • news
    13.11.2017 Researchers learned more about HIV

    As The Deccan Chronicle notes, scientists from the University of Chicago have found out how HIV spreads throughout the body. Probably, the discovery of the scientists may lead to the development of new drugs for HIV infection. According to the scientists, when the cell infected, HIV makes the cell to form a small capsule with the virus from its membrane.

  • news
    09.11.2017 ANANTA MEDICARE took part in the international pharmaceutical exhibition CPhI Worldwide in Frankfurt, Germany

    The largest annual international pharmaceutical exhibition CPhI Worldwide took place in Frankfurt am Main, Germany on October 24-26, 2017. More than 45,000 pharmacy visitors have visited CPhI Worldwide and other events, such as ICSE, InnoPack, P-MEC and FDF. More than 2,500 companies from 153 countries took part in the exhibition and more than 150 industry seminars were held.